Skip to main content
. 2017 Jun;8(3):430–440. doi: 10.21037/jgo.2017.05.04

Figure 1.

Figure 1

Distinct molecular signatures of BTCs. Shown is a schematic of the biliary tract and gallbladder, along with common genetic aberrations seen in intrahepatic and extrahepatic cholangiocarcinoma, and GBC. Red font indicates targetable genes.